The Latest Breaking News from Mylan

One Lot of a Medication Used to Prevent Alcohol Relapse Failed a Dissolution Test in Nationwide Recall

A single lot of acamprosate was recalled after failing dissolution testing. Patients should check with a pharmacy without interrupting treatment.

Medical Daily · Sep 2

Biocon shares jump 6% as Mylan likely exits drugmaker after Rs 3,481 crore stake sale

Biocon shares experienced a significant jump of over 6% on Tuesday. Viatris-owned Mylan intends to sell a substantial stake, exiting the Indian drugmaker. This stake sale represents 5.64% of Biocon's outstanding shares. The offer's floor price was set at a discount to the previous closing price. Block deals totaling nearly…

The Economic Times · Jul 14

The Best Covered Call Strategy to Trade High-Yielding Pfizer Stock and Earn Extra Income

Income investors tend to gravitate towards covered calls, and blue-chip high yielding stocks are a great place to start. Pfizer (PFE) has been a strong performer in 2026 and is up 9.64% so far this year.

Barchart · Mar 12

Telangana DCA cancels Mylan Laboratories alprazolam manufacturing licence

Telangana Drugs Control Administration cancels Mylan Laboratories' manufacturing license for alprazolam due to unauthorized diversion of the drug.

The Hindu · Feb 14, 2024

How to Buy PFE For a 7% Discount, or Achieve a 16% Annual Return

Selling cash secured puts on stocks an investor is happy to take ownership of is a great way to generate some extra income.

Barchart · Dec 5, 2023

Is the Rally Getting Long in the Tooth? Try These Bear Call Spread Trades

Traders should have a bearish outlook on the stock and ideally look to enter when the stock has a high implied volatility rank.

Barchart · Jul 26, 2023

Manchin war chest could help, and hurt, if he runs in 2024

Should Sen. Joe Manchin III seek reelection next year, the West Virginia Democrat would almost certainly rely on a network of K Street lobbyists, corporate executives and out-of-state donors to help fund his campaign.

Tribune News Service · Feb 17, 2023

Manchin war chest could help, and hurt, if he runs in 2024 - Roll Call

Sen. Joe Manchin has a $9 million campaign account but could face heat for raising less than 2 percent in his home state of West Virginia.

Roll Call · Feb 16, 2023

Short Circuit: A Roundup of Recent Federal Court Decisions

Measles, tough weeds, and a COVID hoax.

Reason · Aug 5, 2022

Median pay for executives at the largest companies surged last year. A few shareholders are crying foul

While it's surely not worth dwelling over, it nonetheless merits note: The highest-paid CEOs and their top-level colleagues rake in more money in one year — typically way more — than most of us will see in a lifetime.

Tribune News Service · Jul 5, 2022